ZNF829
gene geneOn this page
Also known as DKFZp779O175
Summary
ZNF829 (zinc finger protein 829, HGNC:34032) is a protein-coding gene on chromosome 19q13.12, encoding Zinc finger protein 829 (Q3KNS6). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in nucleus.
Source: NCBI Gene 374899 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 27 total
- MANE Select transcript:
NM_001037232
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:34032 |
| Approved symbol | ZNF829 |
| Name | zinc finger protein 829 |
| Location | 19q13.12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DKFZp779O175 |
| Ensembl gene | ENSG00000185869 |
| Ensembl biotype | protein_coding |
| Entrez | 374899 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 3 protein_coding, 1 retained_intron
ENST00000391711, ENST00000520907, ENST00000520965, ENST00000898763
RefSeq mRNA: 2 — MANE Select: NM_001037232
NM_001037232, NM_001171979
CCDS: CCDS42557, CCDS59380
Canonical transcript exons
ENST00000391711 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002123122 | 36916011 | 36916291 |
| ENSE00002130171 | 36888124 | 36892471 |
| ENSE00002507445 | 36907929 | 36908024 |
| ENSE00003487087 | 36908333 | 36908459 |
| ENSE00003566113 | 36915130 | 36915251 |
| ENSE00003667042 | 36914965 | 36915022 |
Expression profiles
Bgee: expression breadth ubiquitous, 189 present calls, max score 84.34.
FANTOM5 (CAGE): breadth broad, TPM avg 1.7210 / max 31.1260, expressed in 908 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 180701 | 0.8644 | 494 |
| 180700 | 0.8304 | 484 |
| 180699 | 0.0167 | 4 |
| 180702 | 0.0096 | 3 |
Top tissues by expression
233 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 84.34 | gold quality |
| secondary oocyte | CL:0000655 | 80.14 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 79.15 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 77.52 | gold quality |
| calcaneal tendon | UBERON:0003701 | 75.42 | gold quality |
| ventricular zone | UBERON:0003053 | 74.48 | gold quality |
| ganglionic eminence | UBERON:0004023 | 74.05 | gold quality |
| endothelial cell | CL:0000115 | 73.23 | silver quality |
| cortical plate | UBERON:0005343 | 72.68 | gold quality |
| testis | UBERON:0000473 | 72.32 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 72.17 | gold quality |
| right testis | UBERON:0004534 | 72.10 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 71.73 | gold quality |
| left testis | UBERON:0004533 | 71.59 | gold quality |
| parotid gland | UBERON:0001831 | 71.21 | gold quality |
| stromal cell of endometrium | CL:0002255 | 69.59 | gold quality |
| superficial temporal artery | UBERON:0001614 | 69.59 | gold quality |
| oocyte | CL:0000023 | 69.31 | silver quality |
| islet of Langerhans | UBERON:0000006 | 68.71 | gold quality |
| tendon | UBERON:0000043 | 68.63 | gold quality |
| endometrium | UBERON:0001295 | 67.86 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 67.82 | silver quality |
| amniotic fluid | UBERON:0000173 | 67.56 | silver quality |
| smooth muscle tissue | UBERON:0001135 | 67.16 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 67.11 | silver quality |
| oviduct epithelium | UBERON:0004804 | 67.01 | silver quality |
| upper arm skin | UBERON:0004263 | 66.79 | gold quality |
| epithelium of mammary gland | UBERON:0003244 | 66.64 | silver quality |
| gingival epithelium | UBERON:0001949 | 66.60 | gold quality |
| mammary duct | UBERON:0001765 | 66.55 | silver quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-6386 | no | 351.97 |
| E-CURD-10 | no | 250.51 |
| E-ANND-3 | no | 6.01 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
112 targeting ZNF829, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-3924 | 100.00 | 72.09 | 2394 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-3120-5P | 100.00 | 65.56 | 965 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-4789-3P | 99.99 | 70.75 | 2484 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-548AW | 99.99 | 72.57 | 3559 |
| HSA-MIR-4482-3P | 99.98 | 72.50 | 3147 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-512-3P | 99.97 | 67.35 | 1049 |
| HSA-MIR-6888-3P | 99.97 | 65.95 | 1170 |
| HSA-MIR-651-3P | 99.94 | 73.48 | 5177 |
| HSA-MIR-3119 | 99.92 | 71.34 | 2390 |
| HSA-MIR-5680 | 99.91 | 69.83 | 3421 |
| HSA-MIR-1297 | 99.91 | 73.41 | 3162 |
| HSA-MIR-6809-3P | 99.91 | 71.45 | 3814 |
| HSA-MIR-627-3P | 99.90 | 71.42 | 3316 |
| HSA-MIR-95-5P | 99.89 | 72.17 | 3973 |
| HSA-MIR-3065-3P | 99.87 | 70.25 | 1407 |
| HSA-MIR-579-3P | 99.86 | 71.66 | 3628 |
| HSA-MIR-664B-3P | 99.84 | 71.65 | 3590 |
| HSA-MIR-944 | 99.82 | 70.85 | 3042 |
| HSA-MIR-489-3P | 99.80 | 66.46 | 839 |
| HSA-MIR-2052 | 99.79 | 69.37 | 2031 |
Cross-species orthologs
0 orthologs
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631)
Protein
Protein identifiers
Zinc finger protein 829 — Q3KNS6 (reviewed: Q3KNS6)
All UniProt accessions (1): Q3KNS6
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q3KNS6-1 | 1 | yes |
| Q3KNS6-2 | 2 | |
| Q3KNS6-3 | 3 |
RefSeq proteins (2): NP_001032309, NP_001165450 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352
UniProt features (15 total): zinc finger region 10, splice variant 3, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q3KNS6-F1 | 73.14 | 0.29 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 43 (showing top):
MASSARWEH_TAMOXIFEN_RESISTANCE_UP, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, STK33_SKM_DN, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, RYBP_TARGET_GENES, ZBTB18_TARGET_GENES, ZNF30_TARGET_GENES, ZNF331_TARGET_GENES, ZNF350_TARGET_GENES, ZNF524_TARGET_GENES, ZNF577_TARGET_GENES, ZNF8_TARGET_GENES, ZSCAN31_TARGET_GENES, MIR340_5P, MIR95_5P
GO Biological Process (4): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355), regulation of macromolecule metabolic process (GO:0060255), regulation of primary metabolic process (GO:0080090)
GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of metabolic process | 2 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| macromolecule metabolic process | 1 |
| primary metabolic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
428 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF829 | OR5L1 | Q8NGL2 | 447 |
| ZNF829 | BLTP3B | A0JNW5 | 431 |
| ZNF829 | LEKR1 | Q6ZMV7 | 400 |
| ZNF829 | PHYHD1 | Q5SRE7 | 360 |
| ZNF829 | KCNRG | Q8N5I3 | 307 |
| ZNF829 | SH2D2A | Q9NP31 | 263 |
| ZNF829 | ATF7 | P17544 | 254 |
| ZNF829 | LPCAT2 | Q7L5N7 | 246 |
| ZNF829 | CCDC82 | Q8N4S0 | 231 |
| ZNF829 | PBX2 | P40425 | 230 |
| ZNF829 | MACROD2 | A1Z1Q3 | 222 |
| ZNF829 | POU2F2 | P09086 | 202 |
| ZNF829 | ARK2N | Q96B23 | 196 |
| ZNF829 | CAMTA1 | Q9Y6Y1 | 192 |
| ZNF829 | TRIM13 | O60858 | 188 |
IntAct
13 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TRIM28 | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF829 | TRIM28 | psi-mi:“MI:0914”(association) | 0.530 |
| STAT3 | ZNF829 | psi-mi:“MI:0915”(physical association) | 0.490 |
| APPL1 | ZNF829 | psi-mi:“MI:0915”(physical association) | 0.490 |
| ZNF829 | ECE1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ZNF829 | SUV39H1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| KDM1A | ZNF829 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ZNF829 | TRIM28 | psi-mi:“MI:0914”(association) | 0.350 |
| CBX5 | ZNF568 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (27): TRIM28 (Affinity Capture-MS), AIM1 (Affinity Capture-MS), ZNF829 (Two-hybrid), ZNF829 (Two-hybrid), AIM1 (Affinity Capture-MS), TRIM28 (Affinity Capture-MS), ZNF829 (Two-hybrid), ZNF829 (Two-hybrid), ZNF829 (Two-hybrid), ZNF829 (Two-hybrid), CARD9 (Two-hybrid), ZNF587 (Two-hybrid), TLK1 (Two-hybrid), FBXO17 (Two-hybrid), ZNF829 (Affinity Capture-MS)
ESM2 similar proteins: A2RRD8, A6NHJ4, B4DX44, O75346, P10077, P10755, P15621, P16372, P16373, P51786, P52737, P85977, Q0VGE8, Q14588, Q147U1, Q15928, Q15973, Q2M3X9, Q3KNS6, Q3MIS6, Q494X3, Q5HY98, Q5RBQ3, Q5REK1, Q5VIY5, Q60585, Q61751, Q6GQR8, Q7L2R6, Q7TSH9, Q8IYX0, Q8N782, Q8N823, Q8N988, Q8N9F8, Q8NA42, Q8NCK3, Q8NDP4, Q8NEP9, Q8TC21
Diamond homologs: A0A1W2PQL4, A6NK75, A6NN14, A6NNF4, A6NP11, A8MQ14, A8MTY0, A8MUV8, A8MXY4, B4DX44, B4DXR9, E9PYI1, O14628, O43345, O75290, O75346, O75373, O75437, O95780, P0CB33, P0DKX0, P0DPD5, P16373, P17019, P17038, P21506, P35789, P52736, P52738, P52744, Q03923, Q03924, Q03936, Q03938, Q05481, Q14586, Q14593, Q14929, Q15928, Q3KNS6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
27 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 20 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
739 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:36908327:CCTTA:C | donor_loss | 1.0000 |
| 19:36908328:CTTAC:C | donor_loss | 1.0000 |
| 19:36908329:TTAC:T | donor_loss | 1.0000 |
| 19:36908330:TA:T | donor_loss | 1.0000 |
| 19:36908331:A:AG | donor_loss | 1.0000 |
| 19:36908331:AC:A | donor_gain | 1.0000 |
| 19:36908332:C:G | donor_loss | 1.0000 |
| 19:36908332:CC:C | donor_gain | 1.0000 |
| 19:36908332:CCCA:C | donor_gain | 1.0000 |
| 19:36908335:A:AC | donor_gain | 1.0000 |
| 19:36908336:C:CC | donor_gain | 1.0000 |
| 19:36908371:T:TA | donor_gain | 1.0000 |
| 19:36914961:ACACC:A | donor_loss | 1.0000 |
| 19:36914962:CACC:C | donor_loss | 1.0000 |
| 19:36915020:CAC:C | acceptor_gain | 1.0000 |
| 19:36915023:C:CA | acceptor_loss | 1.0000 |
| 19:36915033:G:C | acceptor_gain | 1.0000 |
| 19:36915033:G:GC | acceptor_gain | 1.0000 |
| 19:36892467:CAGAT:C | acceptor_gain | 0.9900 |
| 19:36892468:AGATC:A | acceptor_loss | 0.9900 |
| 19:36892469:GATCT:G | acceptor_loss | 0.9900 |
| 19:36892470:ATCTG:A | acceptor_loss | 0.9900 |
| 19:36892471:TCT:T | acceptor_loss | 0.9900 |
| 19:36892472:C:CA | acceptor_loss | 0.9900 |
| 19:36892472:C:CC | acceptor_gain | 0.9900 |
| 19:36892473:T:G | acceptor_loss | 0.9900 |
| 19:36907924:CTT:C | donor_loss | 0.9900 |
| 19:36907926:TACCT:T | donor_loss | 0.9900 |
| 19:36907927:A:C | donor_loss | 0.9900 |
| 19:36907928:C:CA | donor_loss | 0.9900 |
AlphaMissense
2896 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:36891540:A:C | F417L | 0.993 |
| 19:36891540:A:T | F417L | 0.993 |
| 19:36891542:A:G | F417L | 0.993 |
| 19:36891624:A:C | F389L | 0.993 |
| 19:36891624:A:T | F389L | 0.993 |
| 19:36891626:A:G | F389L | 0.993 |
| 19:36891876:A:C | F305L | 0.993 |
| 19:36891876:A:T | F305L | 0.993 |
| 19:36891878:A:G | F305L | 0.993 |
| 19:36891960:A:C | F277L | 0.991 |
| 19:36891960:A:T | F277L | 0.991 |
| 19:36891962:A:G | F277L | 0.991 |
| 19:36891607:A:G | L395P | 0.986 |
| 19:36891595:T:G | Q399P | 0.984 |
| 19:36891708:A:C | F361L | 0.983 |
| 19:36891708:A:T | F361L | 0.983 |
| 19:36891710:A:G | F361L | 0.983 |
| 19:36892044:A:C | F249L | 0.983 |
| 19:36892044:A:T | F249L | 0.983 |
| 19:36892046:A:G | F249L | 0.983 |
| 19:36891601:C:G | R397P | 0.981 |
| 19:36891523:A:G | L423P | 0.979 |
| 19:36891792:A:C | F333L | 0.979 |
| 19:36891792:A:T | F333L | 0.979 |
| 19:36891794:A:G | F333L | 0.979 |
| 19:36892128:A:C | F221L | 0.979 |
| 19:36892128:A:T | F221L | 0.979 |
| 19:36892130:A:G | F221L | 0.979 |
| 19:36891933:A:C | H286Q | 0.978 |
| 19:36891933:A:T | H286Q | 0.978 |
dbSNP variants (sampled 300 via entrez): RS1000199584 (19:36904097 C>T), RS1000306902 (19:36897797 A>G), RS1000366600 (19:36890588 C>G,T), RS1000415186 (19:36910837 T>C), RS1000440391 (19:36890854 T>C), RS1000680411 (19:36897565 T>C), RS1000693752 (19:36914366 T>A), RS1000843371 (19:36916961 C>G,T), RS1001085538 (19:36888437 C>G,T), RS1001221676 (19:36902856 T>A,C,G), RS1001382571 (19:36888910 C>T), RS1001388283 (19:36896725 T>C), RS1001394558 (19:36902382 C>T), RS1001453134 (19:36909542 C>G), RS1001850578 (19:36915121 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST90002383_279 | Hematocrit | 5.000000e-10 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004348 | hematocrit |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
16 total (human), top 16 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| GSK-J4 | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| sodium arsenite | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| abrine | increases expression | 1 |
| Vorinostat | increases expression | 1 |
| Air Pollutants | affects expression, increases abundance | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Cisplatin | increases expression | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Valproic Acid | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Particulate Matter | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.